sb 203580 has been researched along with glycine in 6 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (glycine) | Trials (glycine) | Recent Studies (post-2010) (glycine) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 35,163 | 756 | 8,415 |
| Protein | Taxonomy | sb 203580 (IC50) | glycine (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 1.4852 | |
| Sodium- and chloride-dependent glycine transporter 1 | Homo sapiens (human) | 106 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.3253 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.3253 | |
| Sodium- and chloride-dependent glycine transporter 2 | Homo sapiens (human) | 128 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, JW; Cameron, PM; Fitzgerald, CE; O'Keefe, SJ; Patel, SB; Pikounis, VB; Scapin, G; Zaller, D | 1 |
| Anwyl, R; Gisabella, B; Rowan, MJ | 1 |
| Chalothorn, D; Faber, JE; Jackson, LF; Lee, DC; Zhang, H | 1 |
| Clay, WC; Condreay, JP; Hall, M; Holbrook, J; Livermore, D; Michel, AD; Ng, SW; Roman, S; Senger, S; Thompson, K | 1 |
| Chen, Q; Fan, L; He, Z; Jiang, L; Liu, L; Lu, Y; Qin, X; Zhong, X | 1 |
| Ameen, M; Arthur Ataam, J; Bharucha, N; Bruyneel, AAN; Diecke, S; Feyen, DAM; Furihata, T; Gavidia, AA; Karakikes, I; Kaur, B; Lim, EW; Martinez-Amador, N; Mercola, M; Metallo, CM; Monte, E; Nair, P; Perea-Gil, I; Seeger, T; Serrano, R; Snyder, MP; Termglinchan, V; Vadgama, N | 1 |
6 other study(ies) available for sb 203580 and glycine
| Article | Year |
|---|---|
Structural basis for p38alpha MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity.
Topics: Amino Acid Sequence; Animals; Cloning, Molecular; Enzyme Inhibitors; Glycine; Imidazoles; Inhibitory Concentration 50; Kinetics; Mice; Mitogen-Activated Protein Kinase 14; Mitogen-Activated Protein Kinases; Models, Chemical; Models, Molecular; Molecular Sequence Data; Mutation; Peptides; Protein Binding; Protein Isoforms; Protein Structure, Tertiary; Pyridazines; Pyridines; Pyrimidines; Quinazolines; Sequence Homology, Amino Acid | 2003 |
Mechanisms underlying the inhibition of long-term potentiation by preconditioning stimulation in the hippocampus in vitro.
Topics: Animals; Anticonvulsants; Cyclopropanes; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Flavonoids; Glycine; Hippocampus; Imidazoles; In Vitro Techniques; Long-Term Potentiation; Male; Methoxyhydroxyphenylglycol; Neural Inhibition; Pyridines; Rats; Rats, Wistar; Synapses; Time Factors | 2003 |
Transactivation of epidermal growth factor receptor mediates catecholamine-induced growth of vascular smooth muscle.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Anthracenes; Aorta, Thoracic; Bacterial Proteins; Benzopyrans; Butadienes; Catheterization; Cell Division; Dipeptides; ErbB Receptors; Flavonoids; Glycine; Hydroxamic Acids; Imidazoles; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitriles; Organ Culture Techniques; Phenylephrine; Phosphorylation; Protein Processing, Post-Translational; Pyridines; Quinazolines; Rats; Receptors, Adrenergic, alpha-1; Thrombin; Tyrphostins | 2004 |
Identification of regions of the P2X(7) receptor that contribute to human and rat species differences in antagonist effects.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Allosteric Regulation; Allosteric Site; Amino Acid Sequence; Animals; Cell Line; Cloning, Molecular; Dose-Response Relationship, Drug; Glycine; Humans; Imidazoles; Molecular Sequence Data; Mutagenesis, Site-Directed; Piperazines; Plasmids; Polymorphism, Single Nucleotide; Protein Binding; Protein Structure, Tertiary; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridines; Pyridoxal Phosphate; Radioligand Assay; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Sequence Alignment; Species Specificity; Transfection | 2008 |
Glycine-induced cytoprotection is mediated by ERK1/2 and AKT in renal cells with ATP depletion.
Topics: Adenosine Triphosphate; Animals; Cell Death; Cytoprotection; Dogs; Glycine; HEK293 Cells; Humans; Imidazoles; Kidney; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridines; Receptors, Glycine; Signal Transduction | 2011 |
Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy.
Topics: Activating Transcription Factor 4; Adenosine Triphosphate; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cardiomyopathy, Dilated; Drug Evaluation, Preclinical; Glucose; Glycine; Humans; Imidazoles; Induced Pluripotent Stem Cells; Molecular Targeted Therapy; Mutation; Myocytes, Cardiac; Phosphoglycerate Dehydrogenase; Protein Kinase Inhibitors; Pyridines; Serine; Troponin T | 2022 |